Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rafael Holdings ( (RFL) ) has shared an update.
On July 14, 2025, Rafael Holdings elected N. Scott Fine as an ex-officio (non-voting) director and vice chairman. Fine, who has a notable history in executive roles, resigned as CEO of Cyclo Therapeutics, a subsidiary of Rafael Holdings, effective July 31, 2025. His transition includes a severance package and continued equity vesting. Concurrently, Rafael Holdings’ Board of Directors amended the company’s by-laws to incorporate ex-officio directors and the vice chairman role, reflecting a strategic shift in governance structure.
Spark’s Take on RFL Stock
According to Spark, TipRanks’ AI Analyst, RFL is a Neutral.
Rafael Holdings’ overall score reflects significant financial challenges, including declining revenues and negative profitability, which weigh heavily on its financial performance. While the technical analysis also indicates bearish signals, the recent merger with Cyclo Therapeutics provides a potential positive outlook by strengthening strategic assets and leadership. However, the valuation remains unattractive with a negative P/E ratio. Overall, the company’s current financial struggles and weak technical indicators are only partially offset by recent strategic moves, resulting in a moderate stock score.
To see Spark’s full report on RFL stock, click here.
More about Rafael Holdings
Average Trading Volume: 280,039
Technical Sentiment Signal: Buy
Current Market Cap: $74.42M
For a thorough assessment of RFL stock, go to TipRanks’ Stock Analysis page.